Pharmaceutical Innovation

Eli Lilly to Launch Groundbreaking Obesity Drug Tirzepatide in India by 2025

Eli Lilly to Launch Groundbreaking Obesity Drug Tirzepatide in India by 2025

Global pharmaceutical giant Eli Lilly is gearing up to introduce Tirzepatide, its revolutionary weight-loss and diabetes treatment, in India by 2025 under the brand name Mounjaro. “India represents a vibrant market with its large and growing population, increasing health issues related to obesity, diabetes, and cancer, alongside rising health expenditure. This combination fills us with […]